Anukanon, S.; Pongpamorn, P.; Tiyabhorn, W.; Chatwichien, J.; Niwetmarin, W.; Sessions, R. B.; Ruchirawat, S.; Thasana, N. In silico-guided Rational Drug Design and Semi-synthesis of C(2) Functionalized Huperzine A Derivatives as Acetylcholinesterase Inhibitor. ACS Omega 2021, 6, 19924–19939.

26 Jul 2021
0

Anukanon, S.; Pongpamorn, P.; Tiyabhorn, W.; Chatwichien, J.; Niwetmarin, W.; Sessions, R. B.; Ruchirawat, S.; Thasana, N. In silico-guided Rational Drug Design and Semi-synthesis of C(2) Functionalized Huperzine A Derivatives as Acetylcholinesterase Inhibitor. ACS Omega 2021, 6, 19924–19939.

Tags

Share this

Related Posts

An engineered cell line lacking OGG1 and MUTYH glycosylases implicates the accumulation of genomic 8-oxoguanine as the basis for paraquat mutagenicity. Tajai P, Fedeles BI, Suriyo T, Navasumrit P, Kanitwithayanun J, Essigmann JM, Satayavivad J. Free Radic Biol Med. 2018;116: 64-72.

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New